Sulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life
Conclusion
Oral sulodexide significantly improves both objective and subjective symptoms, as well as functional and psychological aspects of QoL in patients with CVD.
Funding
No funding or sponsorship was received for this study. Sponsorship for article processing charges and open access fees was provided by Alfa Wassermann.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Pain | Drugs & Pharmacology | Gastroenterology | Pain | Psychology | Study | Women